The stealth-stage Stanford spinout is reportedly developing an anti-hand tremor device, and is backed by Alphabet, Johnson & Johnson and corporate joint venture DRX.
Cala Health, a US-based medical device developer backed by healthcare group Johnson & Johnson and internet conglomerate Alphabet, has raised $18m in series A funding according to a regulatory filing on Tuesday.
Cala is working on therapies based on neuroscience discoveries from Stanford University, and more specifically a wearable treatment for hand tremor, according to MedCity News, which cited an alumni briefing from the Stanford Biodesign program.
The stealth-stage company has not revealed details of the funding but its website…
